153 related articles for article (PubMed ID: 26101699)
1. Mogrol represents a novel leukemia therapeutic, via ERK and STAT3 inhibition.
Liu C; Zeng Y; Dai LH; Cai TY; Zhu YM; Dou DQ; Ma LQ; Sun YX
Am J Cancer Res; 2015; 5(4):1308-18. PubMed ID: 26101699
[TBL] [Abstract][Full Text] [Related]
2. Mogrol Derived from Siraitia grosvenorii Mogrosides Suppresses 3T3-L1 Adipocyte Differentiation by Reducing cAMP-Response Element-Binding Protein Phosphorylation and Increasing AMP-Activated Protein Kinase Phosphorylation.
Harada N; Ishihara M; Horiuchi H; Ito Y; Tabata H; Suzuki YA; Nakano Y; Yamaji R; Inui H
PLoS One; 2016; 11(9):e0162252. PubMed ID: 27583359
[TBL] [Abstract][Full Text] [Related]
3. Biological Effects of Hesperetin on Interleukin-6/Phosphorylated Signal Transducer and Activator of Transcription 3 Pathway Signaling in Prostate Cancer PC3 Cells.
Shirzad M; Heidarian E; Beshkar P; Gholami-Arjenaki M
Pharmacognosy Res; 2017; 9(2):188-194. PubMed ID: 28539744
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells.
Wang ST; Ho HJ; Lin JT; Shieh JJ; Wu CY
Cell Death Dis; 2017 Feb; 8(2):e2626. PubMed ID: 28230855
[TBL] [Abstract][Full Text] [Related]
5. Cucurbitacin B inhibits STAT3 and the Raf/MEK/ERK pathway in leukemia cell line K562.
Chan KT; Li K; Liu SL; Chu KH; Toh M; Xie WD
Cancer Lett; 2010 Mar; 289(1):46-52. PubMed ID: 19700240
[TBL] [Abstract][Full Text] [Related]
6. Construction and Optimization of the
Wang S; Xu X; Lv X; Liu Y; Li J; Du G; Liu L
Front Bioeng Biotechnol; 2022; 10():919526. PubMed ID: 35711645
[TBL] [Abstract][Full Text] [Related]
7. Arctigenin enhances chemosensitivity of cancer cells to cisplatin through inhibition of the STAT3 signaling pathway.
Yao X; Zhu F; Zhao Z; Liu C; Luo L; Yin Z
J Cell Biochem; 2011 Oct; 112(10):2837-49. PubMed ID: 21608020
[TBL] [Abstract][Full Text] [Related]
8. Efficient snailase-based production of mogrol from Luo Han Guo extract in an aqueous-organic system.
Zhao Y; Su Y; Li Z; Luo C; Chen Y; Wu X
Enzyme Microb Technol; 2023 Apr; 165():110212. PubMed ID: 36804180
[TBL] [Abstract][Full Text] [Related]
9. Leukemia inhibitory factor can mediate Ras/Raf/MEK/ERK-induced growth inhibitory signaling in medullary thyroid cancer cells.
Arthan D; Hong SK; Park JI
Cancer Lett; 2010 Nov; 297(1):31-41. PubMed ID: 20570039
[TBL] [Abstract][Full Text] [Related]
10. Mogrol-mediated enhancement of radiotherapy sensitivity in non-small cell lung cancer: a mechanistic study.
Yin Z; Zhang X; Sun X; Huo Y; Ji N; Chen K
Am J Physiol Cell Physiol; 2024 Jun; 326(6):C1753-C1768. PubMed ID: 38682239
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of mogrol against Aβ
Chen G; Liu C; Meng G; Zhang C; Chen F; Tang S; Hong H; Zhang C
J Pharm Pharmacol; 2019 May; 71(5):869-877. PubMed ID: 30585314
[TBL] [Abstract][Full Text] [Related]
12. Activation of ERK and Mutual Regulation of Stat3 and SP1 Contribute to Inhibition of PDK1 Expression by Atractylenolide-1 in Human Lung Cancer Cells.
Xiao Q; Zheng F; Wu J; Tang Q; Wang W; Hann SS
Cell Physiol Biochem; 2017; 43(6):2353-2366. PubMed ID: 29073620
[TBL] [Abstract][Full Text] [Related]
13. [The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways].
Feng Y; Zhou MY; Sun F; Kong Z; Wang J; Sun ZQ; Hu LJ; Wang JL; Hua Q; Yu JP
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):263-275. PubMed ID: 31014051
[No Abstract] [Full Text] [Related]
14. Oxidation of Cucurbitadienol Catalyzed by CYP87D18 in the Biosynthesis of Mogrosides from Siraitia grosvenorii.
Zhang J; Dai L; Yang J; Liu C; Men Y; Zeng Y; Cai Y; Zhu Y; Sun Y
Plant Cell Physiol; 2016 May; 57(5):1000-7. PubMed ID: 26903528
[TBL] [Abstract][Full Text] [Related]
15. 2-D gel electrophoresis-based proteomic analysis reveals that ormeloxifen induces G0-G1 growth arrest and ERK-mediated apoptosis in chronic myeloid leukemia cells K562.
Pal P; Kanaujiya JK; Lochab S; Tripathi SB; Bhatt ML; Singh PK; Sanyal S; Trivedi AK
Proteomics; 2011 Apr; 11(8):1517-29. PubMed ID: 21360677
[TBL] [Abstract][Full Text] [Related]
16. Comparative In vitro metabolism of purified mogrosides derived from monk fruit extracts.
Bhusari S; Rodriguez C; Tarka SM; Kwok D; Pugh G; Gujral J; Tonucci D
Regul Toxicol Pharmacol; 2021 Mar; 120():104856. PubMed ID: 33387567
[TBL] [Abstract][Full Text] [Related]
17. Matrine inhibits BCR/ABL mediated ERK/MAPK pathway in human leukemia cells.
Ma L; Xu Z; Wang J; Zhu Z; Lin G; Jiang L; Lu X; Zou C
Oncotarget; 2017 Dec; 8(65):108880-108889. PubMed ID: 29312576
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a Sensitive LC-MS-MS Method for Quantification of Mogrol in Rat Plasma and Application to Pharmacokinetic Study.
Luo Z; Zhang K; Shi H; Guo Y; Ma X; Qiu F
J Chromatogr Sci; 2017 Mar; 55(3):284-290. PubMed ID: 27884874
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of STAT3-interacting protein 1 (STATIP1) promotes STAT3 transcriptional up-regulation and imatinib mesylate resistance in the chronic myeloid leukemia.
Mencalha AL; Corrêa S; Salles D; Du Rocher B; Santiago MF; Abdelhay E
BMC Cancer; 2014 Nov; 14():866. PubMed ID: 25417721
[TBL] [Abstract][Full Text] [Related]
20. STAT3 and ERK Signaling Pathways Are Implicated in the Invasion Activity by Oncostatin M through Induction of Matrix Metalloproteinases 2 and 9.
Ko HS; Park BJ; Choi SK; Kang HK; Kim A; Kim HS; Park IY; Shin JC
Yonsei Med J; 2016 May; 57(3):761-8. PubMed ID: 26996579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
